MedilinkWM is reinforcing its position and activities in the assisted living sector. The new name for its division dedicated to this sector is Alvolution (previously i-Health). The name has been created to reflect the organisation’s role and position in stimulating the next stage in the evolution of technological advances for home-based intelligent healthcare. These are designed to support independent living for the elderly and those living with long-term health conditions. There are just over 15 million people living with chronic conditions in the UK, and this number is set to rise dramatically.
Rob Chesters, Manager of Alvolution (pictured), explains, “Alvolution is an important initiative for MedilinkWM. At its core is the discovery, collaboration, stimulation, demonstration and promotion of high quality technological initiatives developed by manufacturers for the assisted living sector.
“Under the new name, Alvolution maintains MedilinkWM’s commitment to stimulating demand for assisted living technology, leading and driving the assisted living market, to create better products to deliver quality healthcare. By promoting the role of partnership, best practice and modern technology to support independent living, Alvolution continues to help in the delivery of cost-effective, user-friendly solutions that address the looming crises of an ageing population,” says Rob.
“Estimates indicate that in the UK, the number of people aged 65 or over will rise from 9.3 million to 16.8 million over the next fifty years. According to the Department for Health, currently there are just over 15 million people living with chronic conditions, but by 2030 this is expected to more than double in the over 65s.”
MedilinkWM develops business networks for medical and healthcare companies, resulting in commercial ventures and business growth in the West midlands region of the UK. By bridging the gap between those who innovate and those who manufacture, the organisation increases the viability of companies in the market through technology and knowledge transfer from Universities and the NHS. Sharing advance knowledge of academic and private research, clinical developments and industrial opportunities, it encourages businesses to develop new revenue streams and new products as well as helping diversification from other industries.Annie Ellerton